Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
CG100649
print preview
bookmark
share with colleague
General Information
Company
CrystalGenomics Inc.
Description
Dual-acting cyclooxygenase-2 (COX-2) and carbonic anhydrase inhibitor
Molecular Target
Cyclooxygenase-2 (COX-2)
;
Carbonic anhydrase l (CAI)
Mechanism of Action
Cyclooxygenase-2 (COX-2) inhibitor; NSAID
Latest Stage of Development
Phase III
Indication
Osteoarthritis
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy